Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Histologic features of primary cutaneous melanoma are insufficient for predicting metastatic potential.
• Identifying molecular markers is crucial for risk stratification and early intervention.

Purpose of the Study:

• To identify immunomodulatory genes in primary melanoma tumors associated with the development of distant metastases.
• To evaluate the predictive value of these genes for metastatic disease progression.

Main Methods:

• Gene expression profiling using Human Gene Expression microarray on 37 primary melanoma tumor specimens.
• Differential expression analysis of 74 immunomodulatory genes between patients with and without distant metastases.
• Validation using quantitative real-time polymerase chain reaction.

Main Results:

• Four immunomodulatory genes (c-CBL, CD276, CXCL1, CXCL2) were significantly upregulated in patients who developed distant metastases.
• CXCL1 showed a high predictive value (AUC=0.80) and was the only gene independently predictive of distant metastases via multivariate analysis.
• Upregulation was confirmed by quantitative real-time polymerase chain reaction.

Conclusions:

• CXCL1, CXCL2, c-CBL, and CD276 are strongly associated with metastatic disease development in primary melanoma.
• CXCL1 expression in primary tumors can serve as a predictor of metastatic risk.
• Early identification of high-risk patients may facilitate timely immunotherapy interventions.